During the last session, Climb Bio Inc (NASDAQ:CLYM)’s traded shares were 0.75 million, with the beta value of the company hitting -0.41. At the end of the trading day, the stock’s price was $3.05, reflecting an intraday gain of 1.67% or $0.05. The 52-week high for the CLYM share is $11.55, that puts it down -278.69 from that peak though still a striking 22.95% gain since the share price plummeted to a 52-week low of $2.35. The company’s market capitalization is $205.03M, and the average intraday trading volume over the past 10 days was 0.29 million shares, and the average trade volume was 556.27K shares over the past three months.
Climb Bio Inc (NASDAQ:CLYM) trade information
Climb Bio Inc (CLYM) registered a 1.67% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 1.67% in intraday trading to $3.05, hitting a weekly high. The stock’s 5-day price performance is 1.33%, and it has moved by -34.41% in 30 days. Based on these gigs, the overall price performance for the year is 20.08%. The short interest in Climb Bio Inc (NASDAQ:CLYM) is 4.98 million shares and it means that shorts have 12.93 day(s) to cover.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -46.72%.
CLYM Dividends
Climb Bio Inc is due to release its next quarterly earnings in December. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Also, the Mutual Funds coming in first place with the largest holdings of Climb Bio Inc (CLYM) shares are iShares Russell 2000 ETF and iShares Russell 2000 Value ETF . Data provided on Sep 30, 2024 indicates that iShares Russell 2000 ETF owns about 682.75 shares. This amounts to just over 1.02 percent of the company’s overall shares, with a $2.08 million market value. The same data shows that the other fund manager holds slightly less at 257.47, or about 0.38% of the stock, which is worth about $0.79 million.
